FindTrial
Sign In

Construction and validation of a predictive model for the risk of intestinal acute graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation

Construction and validation of a predictive model for the risk of intestinal acute graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080510
Enrollment
Unknown
Registered
2024-01-31
Start date
2023-08-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aplastic anemia, leukemia, lymphoma, etc.

Interventions

Trail group:none

Sponsors

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 90 Years

Inclusion criteria

Inclusion criteria: ? Patients who meet the allo-HSCT criteria and undergo allo-HSCT; ? Patients with complete medical records covering relevant information including type of transplant, pretreatment regimen, and donor-recipient human leukocyte antigen mating compatibility;

Exclusion criteria

Exclusion criteria: Preoperative comorbid severe gastrointestinal dysfunction;

Design outcomes

Primary

MeasureTime frame
whether intestinal acute graft-versus-host disease occurs;—

Countries

China

Contacts

Public ContactFang Cheng

The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)

elena9502@163.com+86 137 5081 8143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026